What is the role of Sitagliptin in the DPP-4 inhibitor class of drugs, and how does it compare to other medications in this category?
Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
Sitagliptin inhibits the DPP-4 enzyme, which increases incretin levels, enhancing insulin release. It has similar efficacy to other DPP-4 inhibitors but offers a once-daily dosage.